Company / EPS (Diluted)
Centene Corporation EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$4.95
FY2025
5-year range
$2.07 / $4.95
FY2021-FY2025
Trend
+139.1%
vs FY2024
Sector context
#37 of 159
Health Care
What the data says
Centene Corporation's eps (diluted) of $4.95 is higher than 77% of companies in the Health Care sector (FY2025). EPS (Diluted) returned to growth in FY2025 after 3 years of decline, reaching $4.95.
Based on SEC 10-K filings.
4.95 in FY2025 with a 5-year CAGR of +17.0%. Top quartile in the Health Care sector.
Improved from $2.28 to $4.95 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- +16.6%
- 5-Year CAGR
- +17.0%
- 10-Year CAGR
- -
Sector benchmark
Top 23% in Health CareTop 23% of 159This company $4.95 Sector average $2.35
▼
+110.4% above sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 139.1% year-over-year.
- Ranks #37 out of 159 companies in the Health Care sector.
- Lowest eps (diluted) in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.95 | +139.1% |
| FY2024 | $2.07 | -9.2% |
| FY2023 | $2.28 | -26.9% |
| FY2022 | $3.12 | -0.6% |
| FY2021 | $3.14 | +38.9% |
| FY2020 | $2.26 | -3.4% |
| FY2019 | $2.34 | +36.8% |
| FY2018 | $1.71 | -40.6% |
| FY2017 | $2.88 | +28.0% |
| FY2016 | $2.25 | +53.1% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026